Santamarine Synergizes With Cisplatin via ROS/JNK Axis to Selectively Induce Apoptosis and DNA Damage in Oral Cancer Cells In Vitro
Drug Development Research · 2026
DOI: 10.1002/ddr.70327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2026. Verfasst von Hsin-I Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science and Environmental Biology, PhD Program in Life Sciences, College of Life Sciences, Kaohsiung Medical University, Kao…. Hauptthemen laut MEDLINE: Cisplatin, Mouth Neoplasms, Sesquiterpenes, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Kaohsiung Medical University Hospital, Kaohsiung Medical University.
Abstract (Originalsprache)
Santamarine (SAMA), a Michelia compressa ‐derived sesquiterpene lactone, exhibits ROS‑mediated anticancer activity; however, its potential mechanisms and synergy with cisplatin in oral cancer have not been explored. This study investigated SAMA and cisplatin's combined effects and underlying ROS/MAPK mechanisms of action on oral cancer cells. The combination significantly reduced viability (ATP assay) in oral cancer Ca9‑22 and CAL 27 cells compared with either agent alone, with synergistic indices confirming enhanced antiproliferation. Moreover, this combination markedly suppressed colony formation and cell migration. SAMA/cisplatin induced subG1 accumulation and G2/M arrest, elevated cellular and mitochondrial ROS, and promoted apoptosis, as evidenced by increased annexin V positivity and caspase‑3, ‐8, and ‐9 activation, while DNA damage markers γH2AX and 8‑OHdG were also markedly elevated. In contrast, normal oral S‑G cells showed minimal cytotoxic damage and mechanical changes, suggesting selectivity. Mechanistically, JNK inhibition rescued the antiproliferative response and suppressed apoptosis, caspase activation, and DNA damage. Pretreatment with the ROS scavenger NAC attenuated all test effects, confirming ROS dependence. Together, these findings demonstrate that SAMA synergizes with cisplatin to selectively enhance oxidative stress, apoptosis, and DNA damage in oral cancer cells via ROS‑dependent JNK signaling, highlighting its potential as a cisplatin adjunct.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science and Environmental Biology, PhD Program in Life Sciences, College of Life Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Dentistry, Chi-Mei Medical Center, Tainan, Taiwan.
- Department of Healthy Beauty, School of Medical and Health Sciences, Fooyin University, Kaohsiung, Taiwan.
- School of Dentistry, Taipei Medical University, Taipei, Taiwan.
- Department of Molecular Oncology, Institute of Biomedical and Genetic Engineering (IBGE), Islamabad, Pakistan.
- School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
ORCID-Profile: Ammad Ahmad Farooqi, Hsueh-Wei Chang
Förderung
- National Science and Technology Council
- Kaohsiung Medical University Hospital
- Kaohsiung Medical University
- Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation
- Kaohsiung Medical University Research Center
- Kaohsiung Medical University Chung-Ho Memorial Hospital
Zitieren
APA
Lu, H. I., Chen, K. L., Chen, C. Y., Yen, C. Y., Farooqi, A. A., Chien, T. M., Jeng, J. H., Chen, B. H., & Chang, H. W. (2026). Santamarine Synergizes With Cisplatin via ROS/JNK Axis to Selectively Induce Apoptosis and DNA Damage in Oral Cancer Cells In Vitro. Drug Development Research. https://doi.org/10.1002/ddr.70327
Vancouver
Lu HI, Chen KL, Chen CY, Yen CY, Farooqi AA, Chien TM, et al. Santamarine Synergizes With Cisplatin via ROS/JNK Axis to Selectively Induce Apoptosis and DNA Damage in Oral Cancer Cells In Vitro. Drug Development Research. 2026. doi:10.1002/ddr.70327
BibTeX
@article{Lu2026,
author = {Lu, Hsin-I and Chen, Kuan-Liang and Chen, Chung-Yi and Yen, Ching-Yu and Farooqi, Ammad Ahmad and Chien, Tsu-Ming and Jeng, Jiiang-Huei and Chen, Bing-Hung and Chang, Hsueh-Wei},
title = {Santamarine Synergizes With Cisplatin via ROS/JNK Axis to Selectively Induce Apoptosis and DNA Damage in Oral Cancer Cells In Vitro},
journal = {Drug Development Research},
year = {2026},
doi = {10.1002/ddr.70327}
}
EUVIMED